Publisher Correction: Cardiovascular effects of approved drugs for rheumatoid arthritis
Nat Rev Rheumatol
.
2021 May;17(5):306.
doi: 10.1038/s41584-021-00616-z.
Authors
Fabiola Atzeni
1
,
Javier Rodríguez-Carrio
2
3
,
Călin D Popa
4
,
Michael T Nurmohamed
5
,
Gabriella Szűcs
6
,
Zoltán Szekanecz
6
Affiliations
1
Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina, Italy. atzenifabiola@hotmail.com.
2
Department of Functional Biology, Immunology Area, Faculty of Medicine, University of Oviedo, Oviedo, Spain.
3
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
4
Department of Rheumatology, Sint Maartenskliniek Nijmegen, Nijmegen, The Netherlands.
5
Deptartment of Rheumatology, Amsterdam University Medical Center & Reade, Amsterdam, The Netherlands.
6
Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
PMID:
33864040
DOI:
10.1038/s41584-021-00616-z
No abstract available
Publication types
Published Erratum